7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists
- 1 April 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (8) , 971-976
- https://doi.org/10.1016/s0960-894x(98)00148-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agentsMedicinal Research Reviews, 1997
- 5-(N-Oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: Novel, Systemically Active and Broad Spectrum Antagonists for NMDA/glycine, AMPA, and Kainate ReceptorsJournal of Medicinal Chemistry, 1997
- Structure−Activity Relationships in a Series of 2(1H)-Quinolones Bearing Different Acidic Function in the 3-Position: 6,7-Dichloro-2(1H)-oxoquinoline-3-phosphonic Acid, a New Potent and Selective AMPA/Kainate Antagonist with Neuroprotective PropertiesJournal of Medicinal Chemistry, 1996
- Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepinesTrends in Pharmacological Sciences, 1993
- Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 miceEuropean Journal of Pharmacology, 1993
- GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responsesNeuron, 1993
- Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat.Stroke, 1992
- The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsyEuropean Journal of Pharmacology, 1991
- The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in miceEpilepsy Research, 1991
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990